← Open Payments lookup

KEISHA YARBOROUGH: Open Payments

NPI 1982229464 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$388 in 14 payments from 7 companies in 2025. Trend: 2023 $252 · 2024 $720 · 2025 $388

Food & beverage: $388
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.1$125
Neurocrine BioSciences, Inc.4$88
Alkermes, Inc.3$61
Teva Pharmaceuticals USA, Inc.2$38
Supernus Pharmaceuticals, Inc.2$38
Janssen Pharmaceuticals, Inc1$23
ABBVIE INC.1$16

Products named: REXULTI, INGREZZA, ARISTADA, Qelbree, INVEGA SUSTENNA, UZEDY, AUSTEDO XR, VRAYLAR.

Industry payments across SC — which companies pay providers there.